|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 88.98 USD | +1.98% |
|
-1.53% | +171.61% |
| 09-04 | Spyre Therapeutics Insider Sold Shares Worth $2,480,529, According to a Recent SEC Filing | MT |
| 09-04 | Spyre Therapeutics Insider Sold Shares Worth $1,309,410, According to a Recent SEC Filing | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.98% | -1.53% | -13.96% | +20.81% | +171.61% | +423.41% | +493.20% | -51.90% | -48.94% | 7.85B | |
| -1.79% | -2.27% | +7.80% | +59.31% | +69.72% | +43.23% | +99.78% | +9.38% | - | 67.98B | |
| -2.06% | -0.18% | +18.55% | +16.66% | +24.67% | +39.67% | +85.24% | +200.98% | +6,201.83% | 64.94B | |
| -0.31% | +6.54% | -4.72% | +34.04% | -27.44% | -12.96% | +377.83% | +342.97% | +822.50% | 27.58B | |
| +0.86% | +1.65% | +13.78% | +17.80% | +8.99% | -7.74% | -13.58% | -68.96% | - | 26.06B | |
| +0.89% | +1.60% | +8.20% | +63.33% | +57.82% | +27.30% | +18.57% | -58.68% | - | 25.74B | |
| -1.46% | +0.42% | +15.34% | +36.72% | +6.81% | +23.61% | -16.76% | -30.16% | +104.63% | 20.09B | |
| -2.96% | -15.21% | +1.55% | +55.09% | +209.18% | +216.20% | +375.70% | +1,711.92% | +898.52% | 17.16B | |
| +0.16% | -1.41% | -9.14% | +28.32% | +24.99% | -6.89% | +549.27% | - | - | 14.92B | |
| -0.20% | +8.37% | +13.05% | +11.97% | +34.63% | +55.78% | +165.57% | +198.48% | +388.49% | 14.62B | |
| +2.77% | +28.22% | +30.02% | +19.19% | +0.66% | -32.24% | +1,028.53% | +139.20% | +166.74% | 14.04B | |
| -0.28% | +1.37% | +6.02% | +11.11% | -7.09% | +24.99% | +191.88% | +569.99% | +4,761.46% | 12.5B | |
| -0.17% | +1.68% | +0.59% | +18.13% | +30.05% | +196.96% | +195.48% | +27.82% | +1,105.87% | 12.2B | |
| -3.31% | +8.90% | -2.10% | +6.12% | -13.36% | -31.30% | +183.36% | +113.29% | - | 11.89B | |
| -1.66% | +0.87% | -10.63% | +1.73% | +14.45% | +37.18% | +103.07% | +124.03% | +612.94% | 10.11B | |
| -0.02% | +2.21% | +3.85% | +29.14% | +32.55% | +85.22% | +20.39% | +138.35% | - | 9.1B | |
| -1.75% | -2.60% | -8.87% | +14.41% | +9.17% | -18.76% | +136.04% | -28.15% | - | 8.67B | |
| -1.34% | +0.37% | +10.38% | +16.76% | +308.08% | +236.67% | +461.11% | -26.21% | - | 8.56B | |
| +13.16% | +27.61% | +20.50% | +35.06% | +21.04% | +194.51% | +472.98% | - | - | 7.8B | |
| -0.48% | -2.77% | -0.15% | +31.15% | +6.14% | -5.71% | +278.47% | +265.09% | - | 7.41B | |
| Average | +0.10% | +3.20% | +5.00% | +26.34% | +49.13% | +74.46% | +260.31% | +198.75% | +1,501.40% | 19.46B | |
| Weighted average by Cap. | -0.60% | +1.92% | +7.79% | +31.73% | +43.05% | +52.04% | +197.76% | +179.75% | +2,634.67% |
- Stock Market
- Stocks
- SYRE Stock
- Sector Spyre Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
